Berger Dietmar bought GILD
January 2, 2026 · Form 4 insider transaction
Berger Dietmar bought 16,326 shares of Gilead Sciences, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
16,326
Price
N/A
Total value
N/A
InsiderBerger Dietmar
Role—
CompanyGilead Sciences, Inc. (GILD)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 2, 2026
Filing dateJanuary 5, 2026
Shares owned after16,326
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.